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ABSTRACT 
Actuality. The infection with cytomegalovirus (CMV) and Epstein-Barr virus 
(EBV) in the patients with systemic lupus erythematosus (SLE) is of 
particular interest to researchers. SLE is a chronic autoimmune disease of 
unknown etiology that is characterized by multisystemic lesions and is 
potentially life-threatening [1, 2, 3]. 
The severity of the problem is caused by the fact that active viral infection 
can change the manifestations of SLE, but these changes are not always 
specific, so primary care physicians have no reason to suspect active virus 
infection at the first stage of examination of SLE patients and prescribe 
expensive direct virological tests accordingly.  
It has not been definitively established yet which complaints are the most 
meaningful regarding the presence of active viral infection in patients 
with SLE. 
KEYWORDS 
systemic lupus erythematosus,  
cytomegalovirus,  
Epstein Barr virus. 
The purpose of the research was to study complaints in SLE patients with active cytomegalovirus and Epstein-
Barr virus infection and determine their diagnostic value. 
Materials and methods. We randomly enrolled 120 SLE patients – 15 men (12.50%) and 105 women (87.50%) 
aged 18 to 69 years. All patients received treatment at the Rheumatology Department of Lviv Regional Clinical 
Hospital in 2014-2019. The diagnosis of SLE was established based on the diagnostic criteria of the American 
College of Rheumatologists (ACR, 1997). In addition, IgM and IgG antibodies to serum viruses were detected 
for the diagnosis of CMV and EBV infection. To confirm the presence of active viral infection, viruses were 
detected in media (CMV - urine, blood; EBV - oral mucosa, blood) by polymerase chain reaction, resulting in 
28 patients with SLE (23.33%) detected active CMV infection, in 21 patients with SLE (17.50%) - active EBV 
infection and in 15 patients with SLE (12.5%) - a combination of active CMV and EBV infection.  
To achieve the purpose of the study, we identified three steps: the first step was to analyze complaints in patients 
with SLE with active CMV infection and determine their diagnostic value, the second - in the analysis of 
complaints in patients with SLE with active EBV infection and clarify their diagnostic values and the third - in 
the analysis of complaints in patients with SLE with a combination of active CMV and EBV infection and 
clarification of their diagnostic value. We identified three steps: the first step was to analyze complaints in 
patients with SLE with active CMV infection and determine their diagnostic value, the second - in the analysis 
of complaints in patients with SLE with active EBV infection and clarify their diagnostic values and the third - 
in the analysis of complaints in patients with SLE with a combination of active CMV and EBV infection and 
clarification of their diagnostic value.  
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Statistical analysis was performed by calculating the chances of establishing the phase of CMV and EBV 
infection in patients with SLE, using a separate feature - a marker that can be detected during the initial 
examination of the patient. The probable probability of active infection was determined using indicators of 
sensitivity, specificity and accuracy [4]. The actual material was processed on a personal computer in MS Excel 
and SPSS on the basis of conjugation tables with calculation of diagnostic value indicators. The association 
between active infection and a particular patient complaint was considered to be confirmed when the coefficient 
of association exceeded 0.5 (or 0.3 for the coefficient of contingency). 
Research results. It was found that in patients with SLE the presence of active cytomegalovirus infection among 
the main complaints significantly more often indicate the presence of myalgias (coefficient of association 0.79) or 
fever (0.51), or chills of the extremities (0.51), or arthralgia (coefficient of contingent 0.31). The presence of active 
virus Epstein - Barr infections are significantly more often evidenced by the presence of myalgias (coefficient of 
contingent 0.31) or sleep disorders (coefficient of association 0.84), or mood swings (0.74), or fever (0.61), or the 
appearance of new rashes (0.53). On the presence of a combination of active cytomegalovirus and virus Epstein - 
Barr infections significantly more often indicate complaints of sleep disturbances (coefficient of association 0.97) 
or mood swings (0.83), or a feeling of dryness in the eyes (0.51), or fever (0.50). 
Conclusions. The presence of active cytomegalovirus infection in patients with systemic lupus erythematosus 
among the main complaints often indicates the presence of myalgias or fever, or chills of the extremities, or 
arthralgia, the presence of active virus Epstein - Barr infection - myalgia or sleep disturbances, or mood swings, or 
fever, or the appearance of new rashes, the presence of their combination - sleep disturbances or mood swings, or a 
feeling of dryness in the eyes, or fever, which can be used in the diagnostic algorithm. 
The established patterns of complaints allow us to reasonably suspect in patients with systemic lupus 
erythematosus the presence of active cytomegalovirus and Epstein-Barr virus infection, the final verification of 
which requires the use of direct serological tests. 
Citation: O. Abrahamovych, U. Abrahamovych, S. Guta, O. Synenkyi, V. Chemes. (2020) Complaints of the 
Patients with Systemic Lupus Erythematosus and Active Cytomegalovirus and Epstein-Barr Virus Infection; their 
Diagnostic Value. Science Review. 7(34). doi: 10.31435/rsglobal_sr/31102020/7222 
Copyright: © 2020 O. Abrahamovych, U. Abrahamovych, S. Guta, O. Synenkyi, V. Chemes. This is an 
open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, 
distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and 
that the original publication in this journal is cited, in accordance with accepted academic practice. No use, 
distribution or reproduction is permitted which does not comply with these terms. 
 
Actuality. The infection with cytomegalovirus (CMV) and Epstein-Barr virus (EBV) in the 
patients with systemic lupus erythematosus (SLE) is of particular interest to researchers. SLE is a 
chronic autoimmune disease of unknown etiology that is characterized by multisystemic lesions and is 
potentially life-threatening [1, 2, 3]. 
The severity of the problem is caused by the fact that active viral infection can change the 
manifestations of SLE, but these changes are not always specific, so primary care physicians have no 
reason to suspect active virus infection at the first stage of examination of SLE patients and prescribe 
expensive direct virological tests accordingly.  
It has not been definitively established yet which complaints are the most meaningful 
regarding the presence of active viral infection in patients with SLE. 
The purpose of the research was to study complaints in SLE patients with active 
cytomegalovirus and Epstein-Barr virus infection and determine their diagnostic value. 
Materials and methods. We randomly enrolled 120 SLE patients – 15 men (12.50%) and 105 
women (87.50%) aged 18 to 69 years (the average age 39.38±12.40). All patients received treatment at 
the Rheumatology Department of Lviv Regional Clinical Hospital in 2013-2016. The patients 
underwent comprehensive clinical, laboratory and instrumental examinations of their organs and 
systems and were diagnosed with SLE in accordance with the Order of the Ministry for Health of 
Ukraine No. 676 of October 12, 2006 “On the Approval of Protocols for the Provision of Medical Care 
in the Rheumatology Specialty”. The written consents to participate in comprehensive examinations in 
accordance with the principles of Helsinki Human Rights Declaration, Council of Europe Convention 
on Human Rights and Biomedicine, as well as the relevant laws of Ukraine, were duly obtained. 
Routine laboratory tests were performed for all patients with SLE. In addition, we searched for 
the presence of IgM and IgG antibodies to CMV and EBV in blood serum to diagnose viral infections 
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(by means of enzyme-linked immunosorbent assay using Cobas e411 Immunochemical 
Electrochemiluminescent Analyzer, Roche Diagnostics, Switzerland). To confirm the presence of active 
viral infection, viruses were detected by polymerase chain reaction. We found active CMV infection in 
28 patients with SLE (23.33%). Active EBV infection was diagnosed in 21 patients with SLE (17.50%). 
The combination of active CMV and EBV infection was found in 15 patients with SLE (12.5%).  
To achieve the purpose of the study, we identified three steps: the first step was to analyze 
complaints in patients with SLE with active CMV infection and determine their diagnostic value, the 
second - in the analysis of complaints in patients with SLE with active EBV infection and clarify their 
diagnostic values and the third - in the analysis of complaints in patients with SLE with a combination 
of active CMV and EBV infection and clarification of their diagnostic value.  
The statistical analysis was performed by calculating the chances of determining the phase of 
CMV and EBV infection in patients with SLE on the basis of a separate manifestation – a marker that 
can be detected during the initial examination of the patient. The probability of active infection was 
determined using indicators of sensitivity, specificity, and accuracy. Sensitivity (true positive rate) 
reflects the proportion of positive results that correctly identify the sick subject as sick. Specificity 
(true negative rate) reflects the proportion of negative results that correctly identify the healthy subject 
as such, and accuracy reflects the proportion of correct diagnoses based on the information about a 
positive or negative result. We also determined odds ratio (an indicator that shows how much the 
absence or presence of a certain manifestation is associated with the presence or absence of a specific 
disease in the statistical group), the coefficient of association (a statistic that shows how close the 
stochastic relationship between qualitative manifestations, alternative random variables is) [1]. The 
data was processed on a personal computer in MS Excel and SPSS applications on the basis of 
contingency tables with the calculation of diagnostic value, as well as in Statistica 6.0 aplication using 
the methods of descriptive statistics The relationship between active infection and a particular 
complaint was considered to be confirmed when the absolute value of the association coefficient 
exceeded 0.5 (or 0.3 for the contingency coefficient). 
Research results. 
The results of the first step – the analysis of the complaints of patients with SLE and high 
levels of antibodies to CMV – are shown in Table. 1. 
  
Table 1. The prevalence of complaints in the patients with SLE and active CMV 
Complaints of patients with SLE 
Patients with SLE and active 
CMV infection 
Patients with SLE without active 
CMV infection 
n % n % 
1 2 3 4 5 
Joint pain 28 100.00 62 67.39 
Muscle pain (myalgia) 26 92.86 56 60.87 
Morning stiffness 7 25.00 36 39.13 
New rashes 20 71.43 62 67.39 
Hair loss 6 2143 33 35.87 
Itchy skin 6 21.43 12 13.04 
Acrohypothermy 20 71.43 41 44.57 
Fever 17 60.71 31 33.70 
Edema  4 14.29 8 8.70 
Dyspnea 8 28.57 33 35.87 
Cough 2 7.14 16 17.39 
Arterial hypertension 6 21.43 35 38.04 
Palpitations 7 25.00 18 19.57 
Heart pain 6 21.43 10 10.87 
Feeling of skipping beats 3 10.71 10 10.87 
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Continuation of table 1. 
1 2 3 4 5 
Nausea 6 21.43 18 19.57 
Bitter taste in the mouth 10 35.71 28 30.43 
Epigastric pain 8 28.57 24 26.09 
Right upper quadrant  
abdominal pain  
6 21.43 19 20.65 
Appetite disorders 14 50.00 32 34.78 
Painful urination 6 21.43 13 14.13 
Dry eye 16 57.14 34 36.96 
Fingers numbness 3 10.71 6 6.52 
Headaches 14 50.00 34 36.96 
Sleep disorders 6 21.43 9 9.78 
Mood swings 8 28.57 14 15.22 
  
Analyzing the complaints of patients with SLE and CMV infection, we found joint pain in all 
patients with SLE and active CMV infection (100.0%) and in most patients with SLE without active 
CMV infection (67.39%). The sensitivity of the complaint as a marker of active CMV infection 
reached 100.00%, specificity – 31.11%, accuracy – 47.46%. We found statistically significant 
relationship between the presence of this marker and belonging to the group with active CMV 
infection (direct relationship, coefficient of contingency = 0.31). Complaints of muscle pain (myalgia) 
were voiced by 26 patients with SLE and active CMV infection (92,86%) and by 56 patients without 
active CMV infection (60.80%). These complaints were 8.36 times more prevalent in patients with 
SLE and active CMV infection (sensitivity – 92.86%, specificity – 39.13%, accuracy – 51.67%). We 
found a statistically significant relationship between this marker and belonging to the group with 
active CMV infection (direct relationship, coefficient of association = 0.79). The complaints of 
morning stiffness were voiced by 7 patients with SLE and active CMV infection (25.00%). The same 
complaints were voiced by 36 patients with SLE without active CMV infection (39.13%). 71.43% of 
patients with SLE and active CMV infection and 67.39% of patients without active CMV infection 
complained of skin rashes. We received the complaints of hair loss only from 6 patients with SLE and 
active CMV infection (21.43%) and from 33 patients with SLE without active CMV infection 
(35.87%). 20 patients with SLE and active CMV infection (71,43%) and 41 patients with SLE without 
active CMV infection (44,57%) complained of acrohypothermy. These complaints were more 
prevalent in patients with SLE and active CMV infection than in patients with SLE without active 
CMV infection (sensitivity – 71.43%, specificity – 55.43%, accuracy – 59.17%), we found a 
statistically significant relationship between this marker and belonging to the group with active CMV 
infection (direct relationship, coefficient of association = 0.51). 21.43% of patients with SLE and 
active CMV infection and 13.04% of patients without active CMV infection complained of itchy skin. 
17 SLE patients with active CMV infection (60.71%) complained of recurrent fever. 31 patients 
(33.70%) with SLE without active CMV infection had the same complaints. Complaints of fever were 
3.04 times more prevalent in patients with SLE and active CMV infection. The sensitivity of this 
marker for the detection of acute CMV infection was 60.61%, specificity – 66.30%, accuracy – 
65.00%. We found a statistically significant relationship between the marker and belonging to the 
group with active CMV infection (direct relationship, coefficient of association = 0.51). The 
complaints of the edema of the lower extremities were voiced by 4 patients (14.29%) with SLE and 
active CMV infection. These complaints were also voiced by 8 patients with SLE without active CMV 
infection (8.70%). Complaints of dyspnea were voiced by 28.57% of patients with SLE and active 
CMV infection and 35.87% of patients with SLE without active CMV infection. Complaints of cough 
were voiced by 7.14% of patients with SLE and active CMV infection and by 17.39% of patients with 
SLE without acute CMV infection. The cardiovascular system complaints included arterial 
hypertension in 6 patients with SLE and active CMV infection (21.43%). The same complaints were 
voiced by 35 patients with SLE without active CMV infection (38.04%). Complaints of palpitations 
were voiced by 7 patients with SLE and active CMV infection (25.00%) and by 18 SLE patients 
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without active CMV infection (19.57%). Heart pain was detected in 6 patients with SLE and active 
CMV infection (21.43%). The same complaints were also voiced by 10 patients with SLE without 
active CMV infection (10.87%). The feeling of skipping beats disturbed 3 patients with SLE with 
active CMV infection (10.71%) and 10 patients without active CMV infection (10.87%). On the part 
of the digestive system, 6 patients with SLE and active CMV infection (21.43%) and 18 patients 
without active CMV infection (19.57%) complained of nausea. The bitter taste in the mouth bothered 
10 patients with SLE and active CMV infection (35.71%) and 28 patients with SLE without active 
CMV infection (30.43%). Complaints of epigastric pain were voiced by 8 patients with SLE and active 
CMV infection (28.57%) and 24 patients with SLE without active CMV infection (26.09%). 
Complaints of right upper quadrant abdominal pain were voiced by 6 patients with SLE and active 
CMV infection (21.43%) and by 19 patients with SLE without active CMV infection (20.65%). 
Appetite disorders bothered 50.00% of patients with SLE and active CMV infection and 34.78% of 
patients with SLE without active CMV infection. Complaints of painful urination were voiced by 6 
patients with SLE and active CMV infection (21.43%) and by 13 patients with SLE without active 
CMV infection (14.13%). 57.14% of patients with SLE and acute CMV infection and 36.96% of 
patients with SLE without active CMV infection complained of having dry eyes. Complaints of fingers 
numbness were voiced by 3 patients with active CMV infection (10.71%) and by 6 patients without 
active CMV infection (6.52%). 14 patients with SLE and active CMV infection (50.00%) and 34 
patients without active CMV infection (36.96%) complained of headaches. Sleep disorders bothered 6 
SLE patients with active CMV infection (21.43%) and 9 SLE patients without active CMV infection 
(9.78%). Complaints of mood swings were voiced by 28.57% of SLE patients with active CMV 
infection and 9.78% of SLE patients without active CMV infection.  
The results of our research to determine the diagnostic value of complaints in patients with 
SLE and active CMV infection are shown in Table 2. 
 
Table 2. The diagnostic value of complaints in patients with SLE and active CMV infection 
Complaints of 
patients with SLE 
Sensitivity Specificity Accuracy 
Odds 
ratio 
Coefficient of 
association 
Coefficient of 
contingency 
1 2 3 4 5 6 7 
Joint pain 100,00 31,11 - 47,46 1 0,31 
Muscle pain 
(myalgia) 
92,86 39,13 51,67 8,36 0,79 - 
Morning stiffness 26,92 60,87 53,39 0,57 -0,27 - 
New rashes 71,43 32,61 41,67 1,21 0,09 - 
Hair loss 21,43 64,13 54,17 0,49 -0,34 - 
Itchy skin 21,43 86,96 71,67 1,82 0,29 - 
Acrohypothermy 71,43 55,43 59,17 3,11 0,51 - 
Fever 60,71 66,30 65,00 3,04 0,51 - 
Edema  14,29 92,16 75,38 1,96 0,32 - 
Dyspnea 28,57 64,13 55,83 0,72 -0,17 - 
Cough 7,14 82,61 65,00 0,37 -0,46 - 
Arterial hypertension 21,43 61,96 52,50 0,44 -0,38 - 
Palpitations 25,00 80,43 67,50 1,37 0,16 - 
Feeling of skipping 
beats 
10,71 89,13 70,83 0,98 -0,01 - 
Heart pain 21,43 89,13 73,33 2,24 0,38 - 
Nausea 21,43 80,43 66,67 1,21 0,06 - 
Bitter taste in the 
mouth 
35,71 69,57 61,67 1,27 0,12 - 
Epigastric pain 28,57 73,91 63,33 1,13 0,06 - 
Right upper quadrant 
abdominal pain 
21,43 79,35 65,83 1,05 0,02 - 
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Continuation of table 2. 
1 2 3 4 5 6 7 
Appetite disorders 50,00 65,22 61,67 1,88 0,30 - 
Painful urination 21,43 85,87 70,83 1,66 0,25 - 
Dry eye 57,14 65,66 63,78 2,55 0,44 - 
Fingers numbness 10,71 93,48 74,17 1,72 0,26 - 
Headaches 50,00 63,04 60,00 1,71 0,43 - 
Sleep disorders 21,43 90,22 74,17 2,52 0,38 - 
Mood swings 28,57 84,78 71,67 2,23 -0,40 - 
 
Thus, we found that joint pain, muscle pain, acrohypothermy and fever were manifestations of 
active CMV infection in patients with SLE. 
The results of the second step – the analysis of the complaints of patients with SLE and active 
EBV – are shown in Table 3. 
 
Table 3. The prevalence of complaints in patients with SLE with active EBV infection 
Complaints of patients  
with SLE 
Patients with SLE and active 
EBV infection 
Patients with SLE without active 
EBV infection 
n % n % 
Joint pain 17 80.95 73 73.74 
Muscle pain (myalgia) 21 100.00 61 61.62 
Morning stiffness 11 52.38 32 32.32 
New rashes 18 85.71 64 64.65 
Hair loss 11 52.38 28 28.28 
Itchy skin 8 38.10 53 53.54 
Acrohypothermy 6 28.57 12 12.12 
Fever 15 71.43 37 37.38 
Edema  3 14.29 9 9.09 
Dyspnea 11 52.38 30 30.30 
Cough 4 19.05 14 14.14 
Arterial hypertension 9 42.86 32 32.32 
Palpitations 7 33.33 18 18.18 
Heart pain 4 19.05 9 9.09 
Feeling of skipping beats 5 23.81 11 11.11 
Nausea 4 19.05 20 20.20 
Bitter taste in the mouth 9 42.86 29 29.29 
Epigastric pain 7 33.33 25 25.25 
Right upper quadrant 
abdominal pain  
7 33.33 18 18.18 
Appetite disorders 12 57.14 34 34.34 
Painful urination 6 28.57 13 13.13 
Dry eye 13 61.60 37 37.37 
Fingers numbness 2 9.52 7 7.07 
Headaches 12 57.14 36 36.36 
Sleep disorders 9 42.86 6 6.06 
Mood swings 10 47.62 12 12.12 
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Analyzing the complaints of patients with SLE infected with active EBV, we recorded joint 
pain in 17 patients with SLE and active EBV infection (80.95%) and 73 patients with SLE without 
active EBV infection (73.74%). Complaints of muscle pain were voiced by all patients with SLE and 
active EBV infection (100.00%) and by 61 patients with SLE without active EBV infection (61.62%). 
The sensitivity of these complaints as a marker to detect active EBV infection was 100.00%, 
specificity – 38.38%, accuracy – 49.17%. We found a statistically significant relationship between the 
marker and belonging to the group with active EBV infection (direct relationship, coefficient of 
contingency = 0.31). Complaints of morning stiffness were voiced by 11 patients with SLE and active 
EBV infection (52.38%). The same complaints were voiced by 32 patients with SLE without active 
EBV infection (32.32%). 85.71% of patients with SLE and active EBV infection and 64.65% of 
patients with SLE without active EBV infection complained of skin rashes. These complaints were 
3.28 times more prevalent in patients with SLE and active EBV infection than without it (sensitivity – 
85.71%, specificity – 35.35%, accuracy – 44.17%). We found a statistically significant relationship 
between the complaints of skin rashes and belonging to the group with active EBV infection (direct 
relationship, coefficient of association = 0.53). We found complaints of hair loss in 11 patients with 
SLE and active EBV infection (52.38%) and 28 patients with SLE without acute EBV infection 
(28.28%). Complaints of acrohypothermy were voiced by 8 patients with SLE and active EBV 
infection (38.10%) and by 53 patients with SLE without active EBV infection (53.54%). 15 patients 
with SLE and active EBV infection (71.43%) complained of periodic fever. The same complaints were 
voiced by 37 patients with SLE without active EBV infection (37.38%). Thus, complaints of fever 
were 4.19 times more prevalent in patients with SLE and active EBV infection. The sensitivity of this 
marker for the detection of acute EBV infection was 71.43%, specificity – 62.63%, accuracy – 
64.17%. We found a statistically significant relationship between the marker and belonging to the 
group with active CMV infection (direct relationship, coefficient of association = 0.61). Complaints of 
edema of the lower extremities were voiced by the 3 patients with SLE and active EBV infection 
(14.29%). These complaints were also voiced by the 9 patients with SLE without active EBV infection 
(9.09%). Complaints of dyspnea were voiced by 52.38% of patients with SLE and active EBV 
infection and 30.30% of patients with SLE without active EBV infection. Complaints of cough were 
voiced by 19.05% of patients with SLE and active EBV infection and by 14.14% of patients with SLE 
without acute EBV infection. Complaints of arterial hypertension were voiced by 9 patients with SLE 
and active EBV infection (42.86%). The same complaints were voiced by 32 patients with SLE 
without active EBV infection (32.32%). Complaints of palpitations were voiced by the 7 patients with 
SLE and active EBV infection (33.33%) and by 18 patients with SLE without active EBV infection 
(18.18%). The feeling of skipping beats disturbed 19.05% patients with SLE with active CMV 
infection and 9.09% patients without active CMV infection (10.87%). Only 5 patients with SLE and 
active EBV infection (23.81%) complained of heart pain. The same complaints were voiced by 11 
patients with SLE without active EBV infection (11.11%). On the part of the digestive system, 4 
patients with SLE and active EBV infection (19.05%) and 20 patients with SLE without active EBV 
infection (20.20%) complained of nausea. Bitter taste in the mouth bothered 9 patients with SLE and 
active EBV infection (42.86%) and 29 patients with SLE without active EBV infection (29.29%). 
Complaints of epigastric pain were voiced by 7 patients with SLE and active EBV infection (33.33%) 
and 25 patients with SLE without active EBV infection (25.25%). Complaints of right upper quadrant 
abdominal pain were voiced by 7 patient with SLE and active EBV infection (33.33%) and by 18 
patients with SLE without active EBV infection (18.18%). Appetite disorders were reported in 12 
patients with SLE and active EBV infection (57.14%). The same complaints were found in 34.34% of 
patients with SLE without active EBV infection. Complaints of painful urination were voiced by 6 
patients with SLE and active EBV infection (28.57%) and by 13 patients without active EBV infection 
(13.13%). 61.60% of patients with SLE and acute EBV infection and 37.37% of patients with SLE 
without active EBV infection complained of having dry eyes. Complaints of fingers numbness were 
voiced by 2 patients with SLE and active EBV infection (9.52%) and by 7 patients with SLE without 
active EBV infection (7.07%). 12 patients with SLE and active EBV infection (9.52%) and 36 patients 
with SLE without active EBV infection (36.36%) complained of headaches. Sleep disorders bothered 
9 patients with SLE and active EBV infection (42.86%) and 6 patients with SLE without active EBV 
infection (6.06%). Such complaints were more prevalent in patients with active EBV infection than 
without it (sensitivity – 43.86%, specificity – 93.94%, accuracy – 85.00%). There was a statistically 
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significant relationship between the complaints of sleep disorders and belonging to the group with 
active EBV infection (direct relationship, coefficient of association = 0.84). Complaints of mood 
swings were voiced by 47.62% of patients with SLE and active EBV infection and by 12.12% of 
patients with SLE without active EBV infection. These complaints were more prevalent in patients 
with SLE and active EBV infection (sensitivity – 47.62%, specificity – 87.88%, accuracy – 80.83%). 
We found a statistically significant relationship between the marker and belonging to the group with 
active EBV infection (direct relationship, coefficient of association = 0.74). 
The results of our research to determine the diagnostic value of complaints in patients with 
SLE and active EBV infection are shown in Table 4. 
 
Table 4. The diagnostic value of complaints in patients with SLE and active EBV infection  
Complaints of 
patients with SLE 
Sensitivity Specificity Accuracy 
Odds 
ratio 
Coefficient of 
association 
Coefficient of 
contingency 
Joint pain 80,95 26,26 35,83 1,51 0,20 - 
Muscle pain 
(myalgia) 
100,00 38,38 49,17 - 1,00 0,31 
Morning stiffness 52,38 67,68 65,00 2,30 0,39 - 
New rashes 85,71 35,35 44,17 3,28 0,53 - 
Hair loss 52,38 71,71 68,33 2,79 0,47 - 
Itchy skin 38,10 46,46 45,00 0,53 -0,30 - 
Acrohypothermy 28,57 87,88 77,50 2,90 0,49 - 
Fever 71,43 62,63 64,17 4,19 0,61 - 
Edema  14,29 90,91 77,50 1,67 0,25 - 
Dyspnea 52,38 69,70 66,67 2,53 0,43 - 
Cough 19,05 85,86 74,17 1,43 0,18 - 
Arterial hypertension 42,86 67,68 63,33 1,57 0,23 - 
Palpitations 33,33 81,82 73,33 2,25 0,38 - 
Feeling of skipping 
beats 
19,05 90,91 78,33 2,35 0,40 - 
Heart pain 23,81 88,89 77,50 2,50 0,43 - 
Nausea 19,05 79,80 69,17 0,93 -0,04 - 
Bitter taste in the 
mouth 
42,86 70,71 65,83 1,81 0,29 - 
Epigastric pain 33,33 74,75 67,50 1,48 0,19 - 
Right upper quadrant 
abdominal pain 
33,33 81,82 73,33 2,25 0,38 - 
Appetite disorders 57,14 65,66 64,17 2,55 0,44 - 
Painful urination 28,57 86,87 76,67 2,65 0,45 - 
Dry eye 61,90 63,64 63,33 2,84 0,48 - 
Fingers numbness 9,52 92,93 78,33 1,38 0,16 - 
Headaches 57,14 63,64 62,50 2,33 0,40 - 
Sleep disorders 42,86 93,94 85,00 11,63 0,84 - 
Mood swings 47,62 87,88 80,83 6,59 0,74 - 
 
Thus, we found that among the complaints of patients with SLE, muscle pain, the appearance 
of new rashes, fever, sleep disturbances and mood swings are manifestations of active EBV infection. 
The results of the analysis of the main complaints in patients with SLE with a combination of 
active CMV and EBV infection (third step) are presented in table. 5. 
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Table 5. The prevalence of complaints in patients with SLE with a combination of active CMV 
and EBV infection 
Complaints of patients with SLE 
Patients with SLE and 
combination of active CMV and 
EBV infection 
Patients with SLE without 
combination of active CMV 
and EBV infection 
n % n % 
Joint pain 12 80.00 78 74.29 
Muscle pain (myalgia) 15 100.00 67 63.81 
Morning stiffness 5 33.33 38 36.19 
New rashes 9 60.00 73 69.52 
Hair loss 2 13.33 37 35.24 
Itchy skin 5 33.33 51 48.57 
Acrohypothermy 4 26.67 14 13.33 
Fever 10 66.67 42 40.00 
Edema  3 20.00 9 8.57 
Dyspnea 0 0.00 41 39.05 
Cough 1 6.67 17 16.19 
Arterial hypertension 8 53.33 33 31.43 
Palpitations 5 33.33 20 19.05 
Heart pain 3 20.00 10 9.52 
Feeling of skipping beats 4 26.67 12 11.43 
Nausea 5 33.33 19 18.10 
Bitter taste in the mouth 6 40.00 32 30.48 
Epigastric pain 3 20.00 12 11.43 
Right upper quadrant abdominal pain  5 33.33 20 19.05 
Appetite disorders 9 60.00 37 35.24 
Painful urination 4 26.67 15 14.29 
Dry eye 10 66.67 41 39.05 
Fingers numbness 2 13.33 7 6.67 
Headaches 9 60.00 39 37.14 
Sleep disorders 11 73.33 4 3.81 
Mood swings 9 60.00 13 12.38 
 
Analyzing the complaints in patients with SLE with a combination of active CMV and EBV 
infection, we recorded joint pain in 12 patients with SLE (80.00%). The same complaints were found 
in 78 patients with SLE without a combination of active CMV and EBV infections (74.29%). 
Myalgias were detected in all patients with SLE with a combination of active CMV and EBV 
infections (100.00%) and in 67 patients without a combination of active CMV and EBV infection 
(63.81%). Complaints of morning stiffness (33.33%) were recorded in 5 patients with SLE with a 
combination of active CMV and EBV infection. The same complaints were found in 38 patients with 
SLE without a combination of active CMV and EBV infections (36.19%). 60.00% of patients with 
SLE with a combination of active CMV and EBV infection and 69.52% of patients without a 
combination of active CMV and EBV infection complained of skin rashes. We found complaints of 
hair loss in only 2 patients with SLE with active CMV and EBV infection (13.33%) and in 37 patients 
with SLE without active CMV and EBV infection (35.24%). Complaints of acrohypothermy were 
expressed by 5 patients with SLE with active CMV and EBV infection (33.33%) and 51 patients with 
SLE without active CMV and EBV infection (48.57%). We recorded complaints of itchy skin in only 4 
patients with SLE with active CMV and EBV infection (26.67%) and in 14 patients with SLE without 
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active CMV and EBV infection (13.33%). Among the patients we examined, 10 patients with SLE 
with active CMV and EBV infection (66.67%) complained of periodic fever. In the group of patients 
with SLE without active CMV and EBV infection, the same complaints were expressed by 42 patients 
(40.00%). Complaints of fever 3.00 times more common in patients with SLE with active CMV and 
EBV infection. The sensitivity of the marker for the detection of active CMV and EBV infection is 
66.67%, specificity - 60.00%, accuracy - 60.83%. A statistically significant association (direct 
relationship, coefficient of association = 0.50) was established between the marker and belonging to 
the group with active CMV and EBV infection. Complaints of edema of the lower extremities 
(20.00%) were found in 3 patients with SLE with active CMV and EBV infection. These complaints 
were recorded in 9 patients with SLE without active CMV and EBV infection (8.57%). Complaints of 
shortness of breath were recorded only in patients with SLE with active CMV and EBV infection 
(39.05%). In 6.67% of patients with SLE with active CMV and EBV infection and in 16.19% of 
patients with SLE without active CMV and EBV infection, complaints of cough were recorded. 
Among the complaints from the cardiovascular system in 8 patients with SLE with active CMV and 
EBV infection revealed an increase in blood pressure (53.33%). The same complaints were expressed 
by 33 patients with SLE without active CMV and EBV infection (31.43%). Among patients with SLE, 
complaints of palpitations were recorded in 5 patients with SLE with active CMV and EBV infection 
(33.33%) and in 20 patients without active CMV and EBV infection (19.05%). Pain in the heart was 
detected in 4 patients with SLE with active CMV and EBV infection (26.67%). The same complaints 
were expressed by 12 patients with SLE without active CMV and EBV infection (11.43%). On the part 
of the digestive system, 5 patients with SLE with active CMV and EBV infection (33.33%) and 19 
patients without active CMV and EBV infection (18.10%) complained of nausea. The feeling of 
bitterness in the oral cavity bothered 6 patients with SLE with active CMV and EBV infections 
(40.00%) and 32 patients with SLE without active CMV and EBV infections (30.48%). Complaints of 
epigastric pain were expressed by 3 patients with SLE with active CMV and EBV infections (20.00%) 
and 12 patients with SLE without active CMV and EBV infections (11.43%). Complaints of pain in 
the right hypochondrium were recorded in 5 patients with SLE with active CMV and EBV infection 
(33.33%) and in 20 patients with SLE without active CMV and EBV infections (19.05%). Appetite 
disorders were recorded in 9 patients with SLE with active CMV and EBV infection (60.00%). The 
same complaints were found in 37 patients with SLE without active CMV and EBV infection 
(35.24%). Complaints of discomfort during urination were recorded in 4 patients with SLE with active 
CMV and EBV infection (26.67%) and in 15 patients without active CMV and EBV infection 
(14.29%). 66.67% of patients with SLE with active CMV and EBV infection and 39.05% of patients 
with SLE without active CMV and EBV infection complained of dry eyes. The sensitivity of the 
complaint for the detection of active CMV and EBV infection is 66.67%, specificity - 60.95%, 
accuracy - 61.67%. There was a statistically significant association (direct relationship, coefficient of 
association = 0.51) between the marker and belonging to the group with active CMV and EBV 
infection. Among patients with SLE, complaints of finger numbness were recorded in 2 patients with 
active CMV and EBV infection (13.33%) and in 7 patients without active CMV and EBV infection 
(6.67%). Nine patients with SLE with active CMV and EBV infection (60.00%) and 39 patients 
without active CMV and EBV infection (37.14%) complained of headache. Sleep disorders disturbed 
11 patients with SLE with active CMV and EBV infection (73.33%) and 4 patients with SLE without 
active CMV and EBV infection (3.81%). Such a complaint is more often recorded in patients with 
active CMV and EBV infection than without it (sensitivity - 73.33%, specificity - 96.19%, accuracy - 
93.33%). The presence of complaints of sleep disturbances is related to belonging to the group with 
active CMV and EBV infection (direct connection, association coefficient 0.97). Complaints of mood 
swings were found in 60.00% of patients with SLE with active CMV and EBV infection and in 
12.38% of patients with SLE without active CMV and EBV infection. These complaints are more 
common in patients with SLE with active CMV and EBV infection (sensitivity - 60.00%, specificity - 
87.62%, accuracy - 84.17%). We found a significant association between the marker and belonging to 
the group with active CMV and EBV infection (direct relationship, coefficient of association = 0.83). 
The results of our study to study the diagnostic value of complaints in patients with SLE with active 
EBV infection are presented in table 6.  
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Table 6. The diagnostic value of complaints in patients with SLE with a combination of active 
CMV and EBV infection 
Complaints of 
patients with SLE 
Sensitivity Specificity Accuracy 
Odds 
ratio 
Coefficient of 
association 
Coefficient of 
contingency 
Joint pain 80,00 25,71 32,50 1,38 0,16 - 
Muscle pain 
(myalgia) 
100,00 36,19 44,17 - 1 0,26 
Morning stiffness 33,33 63,81 60,00 0,88 -0,06 - 
New rashes 60,00 30,48 34,17 0,66 -0,21 - 
Hair loss 13,33 64,76 58,33 0,28 -0,56 - 
Itchy skin 33,33 51,43 49,17 0,53 -0,31 - 
Acrohypothermy 26,67 86,67 79,17 2,36 0,41 - 
Fever 66,67 60,00 60,83 3,00 0,50 - 
Edema  20,00 91,43 82,50 2,67 0,45 - 
Dyspnea 0,00 60,95 53,33 0,00 -1,00 -0,27 
Cough 6,67 83,81 74,17 0,37 -0,46 - 
Arterial hypertension 53,33 68,57 66,67 2,49 0,43 - 
Palpitations 33,33 80,95 75,00 2,13 0,36 - 
Feeling of skipping 
beats 
20,00 90,48 81,67 2,38 0,41 - 
Heart pain 26,67 88,57 80,83 2,82 0,48 - 
Nausea 33,33 81,90 75,83 2,26 0,39 - 
Bitter taste in the 
mouth 
40,00 69,52 65,83 1,52 0,21 - 
Epigastric pain 20,00 88,57 80,00 1,94 0,32 - 
Right upper quadrant 
abdominal pain 
33,33 80,95 75,00 2,13 0,36 - 
Appetite disorders 60,00 64,76 64,17 2,76 0,47 - 
Painful urination 26,67 85,71 78,33 2,18 0,37 - 
Dry eye 66,67 60,95 61,67 3,12 0,51 - 
Fingers numbness 13,33 93,33 83,33 2,15 0,37 - 
Headaches 60,00 62,86 62,50 2,54 0,43 - 
Sleep disorders 73,33 96,19 93,33 69,44 0,97 - 
Mood swings 60,00 87,62 84,17 10,62 0,83 - 
 
Thus, we found that among the complaints of patients with SLE fever, dry eyes, sleep 
disturbances and mood swings are a manifestation of a combination of active CMV and EBV 
infection.  
Conclusions. About the presence of active cytomegalovirus infection in patients with systemic 
lupus erythematosus among the main complaints is significantly more often evidenced by the presence 
of myalgias (coefficient of association 0.79), or fever (0.51), or acrohypothermy (coefficient of 
association 0.51), or arthralgia (coefficient of contingency 0.31). About the presence of active Epstein 
- Barr viral infection in patients with systemic lupus erythematosus among the main complaints 
significantly more often indicates the presence of sleep disorders (coefficient of association 0.84), or 
mood swings (0.74), or fever (coefficient of association 0.61), or the appearance of new rashes (0.53), 
or myalgias (coefficient of contingency 0.31), About the presence of a combination of active 
cytomegalovirus and virus Epstein- Barr infection in patients with systemic lupus erythematosus 
among the main complaints significantly more often indicates complaints of sleep disturbances 
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(coefficient of association 0.97), or mood swings (0.83), or a feeling of dryness in the eyes (0.51), or 
fever (0.50), which can be used in the diagnostic algorithm. 
The established patterns of complaints in patients with systemic lupus erythematosus can 
reasonably be suspected the presence of active CMV and Epstein - Barr viral infection, the final 
verification of which requires the use of direct serological tests. 
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